AGIO logo

AGIO
Agios Pharmaceuticals Inc

2,921
Mkt Cap
$1.94B
Volume
652,558.00
52W High
$46.00
52W Low
$22.24
PE Ratio
-4.66
AGIO Fundamentals
Price
$33.30
Prev Close
$33.15
Open
$33.14
50D MA
$29.40
Beta
1.09
Avg. Volume
920,975.19
EPS (Annual)
-$7.12
P/B
1.62
Rev/Employee
$100,051.85
$763.78
Loading...
Loading...
News
all
press releases
Rep. Gilbert Ray Cisneros, Jr. Buys Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Stock
Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO). In a filing disclosed on April 07th, the Representative disclosed that they had bought between $1,001 and $15,000 in Agios Pharmaceuticals stock on March 3rd. The tra...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells $113,848.80 in Stock
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) insider James William Burns sold 3,280 shares of Agios Pharmaceuticals stock in a transaction dated Thursday, April 2nd. The shares were...
MarketBeat·8d ago
News Placeholder
Agios Pharmaceuticals (NASDAQ:AGIO) CFO Cecilia Jones Sells 3,141 Shares
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) CFO Cecilia Jones sold 3,141 shares of Agios Pharmaceuticals stock in a transaction on Thursday, April 2nd. The stock was sold at an...
MarketBeat·8d ago
News Placeholder
Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells $113,224.02 in Stock
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) insider Tsveta Milanova sold 3,262 shares of the stock in a transaction that occurred on Thursday, April 2nd. The shares were sold at an...
MarketBeat·8d ago
News Placeholder
Insider Selling: Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells 2,940 Shares of Stock
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) insider Sarah Gheuens sold 2,940 shares of the firm's stock in a transaction dated Thursday, April 2nd. The shares were sold at an average...
MarketBeat·8d ago
News Placeholder
JPMorgan Chase & Co. Raises Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $36.00
JPMorgan Chase & Co. increased their target price on shares of Agios Pharmaceuticals from $31.00 to $36.00 and gave the stock a "neutral" rating in a report on Monday...
MarketBeat·8d ago
News Placeholder
Agios Pharmaceuticals (NASDAQ:AGIO) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says
The Goldman Sachs Group upped their target price on Agios Pharmaceuticals from $28.00 to $32.00 and gave the company a "neutral" rating in a research report on Wednesday...
MarketBeat·13d ago
News Placeholder
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD
Agios Pharmaceuticals jumps 14% as it moves toward accelerated FDA approval for mitapivat in sickle cell disease after key regulatory feedback.
Zacks·13d ago
News Placeholder
Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud...
PR Newswire·13d ago
News Placeholder
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?
Agios Pharmaceuticals (AGIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks·13d ago
<
1
2
...
>

Latest AGIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.